Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre study

Volume: 265, Issue: 8, Pages: 1850 - 1859
Published: Jun 14, 2018
Abstract
Dimethyl-fumarate (DMF) demonstrated efficacy and safety in relapsing–remitting multiple sclerosis (MS) in randomized clinical trials. To track and evaluate post-market DMF profile in real-world setting. Patients receiving DMF referred to Italian MS centres were enrolled and prospectively followed, collecting demographic clinical and radiological data. Among the 735 included patients, 45.4% were naive to disease-modifying therapies, 17.8%...
Paper Details
Title
Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre study
Published Date
Jun 14, 2018
Volume
265
Issue
8
Pages
1850 - 1859
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.